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Abstract
Background: Fluids are often given liberally after the return of spontaneous circulation. However, the optimal fluid 
regimen in survivors of cardiac arrest is unknown. Recent studies indicate an increased fluid requirement in post-
cardiac arrest patients. During hypothermia, animal studies report extravasation in several organs, including the brain. 
We investigated two fluid strategies to determine whether the choice of fluid would influence fluid requirements, 
capillary leakage and oedema formation.
Methods: 19 survivors with witnessed cardiac arrest of primary cardiac origin were allocated to either 7.2% hypertonic 
saline with 6% poly (O-2-hydroxyethyl) starch solution (HH) or standard fluid therapy (Ringer's Acetate and saline 9 mg/
ml) (control). The patients were treated with the randomised fluid immediately after admission and continued for 24 
hours of therapeutic hypothermia.
Results: During the first 24 hours, the HH patients required significantly less i.v. fluid than the control patients (4750 ml 
versus 8010 ml, p = 0.019) with comparable use of vasopressors. Systemic vascular resistance was significantly reduced 
from 0 to 24 hours (p = 0.014), with no difference between the groups. Colloid osmotic pressure (COP) in serum and 
interstitial fluid (p < 0.001 and p = 0.014 respectively) decreased as a function of time in both groups, with a more 
pronounced reduction in interstitial COP in the crystalloid group. Magnetic resonance imaging of the brain did not 
reveal vasogenic oedema.
Conclusions: Post-cardiac arrest patients have high fluid requirements during therapeutic hypothermia, probably due 
to increased extravasation. The use of HH reduced the fluid requirement significantly. However, the lack of brain 
oedema in both groups suggests no superior fluid regimen. Cardiac index was significantly improved in the group 
treated with crystalloids. Although we do not associate HH with the renal failures that developed, caution should be 
taken when using hypertonic starch solutions in these patients.
Trial registration: NCT00347477.
Background
Few studies have described fluid requirements in cardiac
arrest patients [1-3], but fluid infusion after ROSC is
increasingly debated [4]. During hypothermia, animal
studies report extravasation in several organs, including
the brain [5,6]. Whether capillary leakage is present in
man during therapeutic hypothermia, is not documented.
This is of clinical interest, as oedema formation in a vul-
nerable OHCA-brain is considered harmful. Further-
more, this is underlined by the similarity between post-
resuscitation syndrome and sepsis [7,8]. Septic patients
are known to have high fluid requirements, and outcome
is improved by goal-directed fluid therapy [9]. Encour-
aged by the low cardiac output after cardiac arrest [1],
fluid load would appear to be worth attempting. In addi-
tion, the induction of hypothermia by large volumes of
cold intravenous infusions has gained in popularity [10].
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pulmonary bypass has been shown to reduce fluid over-
load [11,12]. Colloids tend to cause less tissue oedema
than crystalloids [13] and, as regards inflammatory-
related leakages, hydroxyethyl starch could have an
'occlusive' effect on damaged capillaries, subsequently
limiting extravasation [14]. Furthermore, hypertonic
solutions recruit fluid from the intracellular space to the
capillaries, and, during CPR in an animal model, these
solutions increased myocardial blood flow and the sur-
vival rate [15].
The aim of the study was to determine whether a capil-
lary leakage was present in OHCA survivors during ther-
apeutic hypothermia. We compared two fluid regimens
and studied the impact on capillary leakage. The inter-
vention group received an additional 500 ml of 7.2%
hypertonic saline with 6% poly (O-2-hydroxyethyl) starch
solution during the first 24 hours, and was compared
with standard therapy. The primary endpoint was the
amount of fluid administered during the first 24 hours.
The secondary endpoint was the magnitude of capillary
leakage as a surrogate marker for oedema formation.
Methods
Ethics
The study was approved by the Regional Committees for
Medical Research Ethics, the Data Inspectorate, the
Directorate for Health and Social Affairs and the Norwe-
gian Medicines Agency. Deferred consent was used, and
the patients' families were entitled to withdraw the
patients at any time. All patients included were informed
about the study when they were able to receive the infor-
mation and signed a written informed consent form.
Study population and environment
The study was performed on 19 patients with witnessed
out-of-hospital cardiac arrest (OHCA) and carried out
between September 2005 and March 2007 at Haukeland
University Hospital (Bergen, Norway), an 1,100-bed hos-
pital serving 600,000 people. All inclusion/exclusion cri-
teria are presented in Table 1. The fluid intervention was
initiated immediately after admission to the emergency
room and continued for the first 24 hours.
Treatment protocol
On admission, the patients were allocated by means of
stratified randomisation to one of two fluid regimens
administered via infusion pumps: Ringer's Acetate and
saline 9 mg/ml (control), or hypertonic colloid,7.2% NaCl
with 6% Hydroxyethyl starch 200/0.5 (HyperHAES® Frese-
nius Kabi, Germany) (HH). Fluid was administered to
achieve the treatment goals listed in Table 2. HH was lim-
ited to 500 ml per 24 hours (20 ml/hr). Further needs for
fluid in the HH group were met by Ringer's Acetate/
saline 9 mg/ml. The control group received Ringer's Ace-
tate and saline 9 mg/ml by turn during the observation
period, in accordance with the standard treatment in the
medical intensive care unit (MICU).
Coronary intervention
Patients with ST elevation, a new left bundle branch
block or cardiogenic shock were referred immediately for
coronary angiography and subsequent percutaneous cor-
onary intervention (PCI).
Magnetic resonance imaging
Before admission to the MICU, after cardiac intervention
and if the patient did not have an intra-aortic-balloon
pump (IABP), magnetic resonance imaging (MRI) of the
brain was planned (1.5 Tesla, conventional morphological
and diffusion sequences). Repeated MRI was scheduled
after 24 and 96 hours.
Intensive care treatment and monitoring
Cardiac arrest data were recorded according to the
Utstein style [16]. In the MICU, monitoring was per-
Table 1: Criteria for inclusion.
Inclusion criteria Exclusion criteria
• Witnessed cardiac arrest with a 
probable cardiac cause. (Ventricular 
fibrillation, tachycardia, asystole 
and pulseless electrical activity)
• Terminal illness, 
strongly in need of 
nursing
• Advanced medical life support 
within 15 minutes
• Primary 
coagulopathy
• Return of spontaneous circulation 
within 60 minutes
• Prehospital fluid load 
>2000 ml
• Comatose when admitted to the 
hospital, (Glasgow Coma Score 3)
• Age 18-80 years
Table 2: Treatment goals.
Parameter Treatment goals
Blood pressure MAP > 60 mmHg
Heart rate 60-100 min-1
Central venous pressure 8-12 mmHg
Temperature 33°C
Blood gases pH 7.35-7.45
pO2 10-12 kPa
pCO2 5-6 kPa
Blood glucose 5-8 mmol/l
Electrolytes Within normal range
Hb >9 g/dl
Diuresis >1 ml/kg/hrs
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with continuous ECG, arterial pressure and continuous
cardiac output registration (PiCCO®, Pulsion Medical
System AG, Germany). Fluid balance was measured as
the total amount of fluid administered intravenously and
enterally in relation to output measured by hourly diure-
sis and 24-hour faecal loss. Systemic vascular resistance
(SVR) was calculated 0, 8, 16 and 24 hours after admis-
sion to the MICU. Vasopressors (dopamine, noradrena-
line, and adrenaline) were administered if the mean
arterial blood pressure was <60 mmHg and the fluid load
proved ineffective, guided by PiCCO measurements.
Dopamine was replaced with noradrenaline if tachycardia
occurred (>100 beats min-1) or if dopamine failed to
achieve the required blood pressure. Sedatives (midazo-
lam, alfentanil) were administered to achieve a motor
activity assessment score of 0 (MAAS). If necessary,
vecuronium was administered to prevent shivering. Ven-
tilation was provided by Evita XL (Dräger Medical,
Lübeck, Germany), using a bi-positive airway pressure
mode. Cooling was initiated outside the hospital for all
patients who had return of spontaneous circulation
(ROSC) and remained unconscious. At the scene, cooling
was performed using icepacks placed on the neck, arm-
pits and groin. A Coolgard catheter (Alsius, California,
USA) was installed in the right femoral vein in the PCI lab
and activated in the MICU, cooling the patient at a rate of
1°C per hour. The target temperature was set at 33°C and
measured in the urine bladder. After 24 hours of cooling,
rewarming at a rate of 0.5°C per hour was stopped at
35.0°C.
Blood samples and sampling of interstitial fluid
Blood samples were taken from the artery line after 0, 8,
16 and 24 hours, and analysed at the Laboratory of Clini-
cal Biochemistry at Haukeland University Hospital. Col-
loid osmotic pressure (COP) was measured at 0, 8, 16 and
24 hours in serum and in interstitial fluid that was sam-
pled using the wick method, installed for 60 minutes [17-
20]. A sterile, multi-filament nylon wick was soaked in
Ringer AC. Using a sterile technique and a needle, the
wick was placed subcutaneously in the midaxillary line.
Three wicks were installed at intervals of 3 cm and cov-
ered by plastic film (Tegaderm, 3M Inc., Canada), to pre-
vent evaporation. COP was measured by means of a
transducer (Gould-Statham, Spectramed, USA), recorded
and amplified with an EasyGraph 240 (Gould Inc., USA).
Statistical analysis
The randomisation was stratified with respect to initial
heart rhythm. Numbered envelopes were distributed
from the MICU and opened when the physician in the
emergency room enrolled a patient, filling in the inclu-
sion criteria. The allocation was generated by the authors.
The sample size was determined by power calculations
on the basis of a required volume load of 8000 ml crystal-
loids during the first 24 hours and a standard deviation of
500 ml. A power of 80% and a significance level of 0.05 for
a two sample t-test suggested that it would be sufficient
to have three patients in each group if HH reduced the
required volume by 30% to 5600 ml. Due to lower power
in non-parametric tests, a higher number was chosen.
The unconscious patients, as well as the neuroradiologist,
were blinded to the treatment. The two treatment groups
were descriptively compared at baseline. Fluid load, urine
output and fluid balance were compared using an exact
Mann-Whitney test. Mixed effects models were used for
group comparisons of repeated measurements of vari-
ables [21]. Time from baseline was entered as a categori-
cal covariate, as well as any differences in developments
in the two groups, and there were assumed to be no
group differences at baseline. The nlme package in R (R
Foundation for Statistical Computing, Vienna, Austria)
was used for linear mixed effects models; SPSS version
15.0 (SPSS Inc., Chicago, IL, USA) was used for other sta-
tistical analyses, and SPSS Sample Power for power calcu-
lation. Numbers were presented as mean (standard
error), or median (low-high). A p-value <0.05 was consid-
ered significant. For categorical covariates with more
than two categories, both overall p-values for the variable
and p-values for individual contrasts are reported.
Results
Patients and outcome
Twenty-four patients were randomised. Five were
excluded due to lack of witnessed arrest, inclusion in
another study, probable respiratory cause of the cardiac
arrest, and age >80 years (Fig 1). Ten patients (two
female) were randomised to HH, and nine (one female) to
the control fluid regimen. The initial heart rhythms and
baseline characteristics are presented in Table 3. There
were no substantial differences between the groups as
regards the aetiology of the arrest. The first temperature
recorded at the hospital was 34.5 (1.4) °C. Survival after
one year was 79%, with no significant difference between
the groups (Table 3).
Fluid
During the first 24 hours in the hospital, the HH group
required significantly less fluid than the control group to
meet the treatment goals. Fluid calculations are pre-
sented in Table 4. The HH group received 6.02 ml/kg
(4.63 - 7.69) of HH during the first 24 hours.
Oedema
COP in plasma showed a significant decline in both
groups (Fig. 2a). The reduction was more rapid in the
control than in the HH group, but the nadir levels were
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interstitial COP showed the same pattern (Fig. 2b). The
drop in COP was significant at all times, except for the
HH group at eight hours. The planned MRI at 0, 24 and
96 hours was performed on seven patients. MRI was per-
formed at 0 and 96 hours on two patients, and on one
patient at 96 hours. The ten patients were equally distrib-
uted between the two groups. Divergence from the plan
was due to technical problems. MRI did not reveal
vasogenic cerebral oedema in any of these patients.
Hemodynamics
SVR dropped significantly in both groups (Fig. 3). The
cardiac index (CI) was 2.2 l/min/m2 (0.2) on admission to
the MICU. At 24 hours, before rewarming, the CI was
higher in both groups and significantly higher in the con-
trol group (Fig. 4). MAP and CVP did not differ signifi-
cantly between groups (Fig. 5). There were no differences
in dose and type of vasopressors between the groups. All
patients needed vasopressors, primarily dopamine in
accordance with the MICU guidelines.
Laboratory data/adverse effects
All laboratory data are listed in Table 5. Serum osmolality
differed significantly, with an increase in the HH group
and a decrease in the control group (p < 0.001). Serum
sodium and chloride increased in both groups. Two
patients who received HH later developed renal failure.
Discussion
We studied fluid requirements and oedema formation in
survivors of OHCA in a prospective, randomised design.
The HH patients received significantly less fluid than the
control patients (4750 ml vs. 8010 ml, p = 0.019). Both
groups had a significant drop in SVR, and demonstrated
increased extravasation through the drop in COP. The
extravasation did not show as vasogenic brain oedema.
The strength of the study lies in its design and the mul-
tiple determination of leakage. The weakness of our
design is that the treating physicians were not blinded.
This could have caused a tendency to replace fluid with
vasopressors. However, there were no differences
between the groups regarding the use of these drugs. Fur-
thermore, as sedation can cause vasodilatation, the use of
sedation may influence the use of fluid and vasopressors.
The lowest doses of sedation were used in all patients to
achieve MAAS 0-1. The number of patients in our study
is not sufficient to determine whether fluid load can
affect neurological outcome/survival.
A large cohort study recently reported on the challeng-
ing aspects of therapeutic hypothermia [22]. In spite of a
positive fluid balance, many patients appear to be hypov-
olemic and have high fluid requirements [2]. Our
reported fluid balance is slightly higher than the balance
reported by Sunde and colleagues, who found a positive
balance of 3455 ml (1594) during 24 hours with similar
treatment goals [3]. Laurent and colleagues used 3500-
Table 3: Prehospital data.
HH Control Total
Number 10 9 19
Age (yrs) 60 (48-74) 60 (22-75)
BMI (kg/m2) 26.2 (22.1-34.1) 26.2 (21.6-35.1)
CA-CPR (min) 1 (0-4) 2 (1-9)
CA-EMS (min) 8.5 (3.0-15.0) 7.0 (5.0-12.0)
Ventricular fibrillation 8 8
Ventricular tachycardia 1 0
Asystole 1 1
No of shocks 5 (1-11) 3 (1-16)
Adrenaline
(mg)
3 (0-15) 1 (0-10)
CA-ROSC
(min)
23 (5-40) 17 (10-39)
Intra-Aortic-Balloon-Pump 3 0
Survivors 8/10 7/9 15/19
Presented as median (range).
CA-CPR- time from cardiac arrest until cardiopulmonary resuscitation was started
CA-EMS- time from cardiac arrest until emergency medical staff was present
CA-ROSC- time from cardiac arrest until return of spontaneous circulation.
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filling pressure in normothermic cardiac arrest patients
[1]. Whether reduced fluid load is of benefit to these
patients remains unknown.
To our knowledge, there are no papers describing
repetitive MRI in the initial treatment of OHCA patients.
Järnum and colleagues performed MRI on 20 cardiac
arrest patients who remained unconscious 72 hours after
normothermia [23]. They found hypoxic-ischemic cere-
bral oedema in two patients during neuropathological
examination post mortem. None of the patients in our
study had a vasogenic cerebral oedema on the MRI,
which indicated an intact blood-brain barrier. Animal
studies have shown that asphyxia is more likely to cause a
disrupted blood-brain barrier [24-26]. The lack of
vasogenic oedema may be the result of cardiac origin of
Figure 1 CONSORT flowchart.
Table 4: Fluid calculations after 24 hours.
HH Control p-valuea
Volume  (ml/24 hrs) 4750 (3150-9075) 8010 (5515 - 12908) 0.019
Volume  (ml/kg/hr) 2.67 (1.54 - 4.55) 4.00 (3.06 - 6.58) 0.004
Diuresis (ml/kg/hr) 0.97 (0.44 - 2.16) 1.43 (0.63 - 2.36) 0.24
Balance (ml/kg/hr) + 1.06 (0.20 - 4.11) +2.27 (0.71 - 5.36) 0.040
Presented as median (range).
a) Exact Mann-Whitney test
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time before initiation of CPR.
We found reduced fluid leakage to the interstitial space
in the HH patients compared with controls. Maintenance
of intravascular COP is one important factor in deter-
mining fluid flux across the capillary membrane. The
decline in COP in plasma was probably due to hemodilu-
tion, which is also reflected in a reduction in haemoglo-
bin and erythrocyte volume fraction.
The reduction in COP in interstitial fluid is probably
caused by the escape of fluid with a lower COP through
the capillaries. Since we observed a simultaneous reduc-
tion in COP both in plasma and interstitial fluid, the
increased extravasation cannot be explained by the differ-
ences in the COP gradient between the groups. However,
the change may be attributed instead to capillary leakage,
which has also been demonstrated in several animal stud-
ies [5,27,28]. This is supported by Nordmark et al., who
found a decreased intravascular volume during hypo-
thermia after cardiac arrest [2]. COP is important in cap-
illary fluid exchange, but is a minor component of the
total osmotic pressure. The significant difference
between the groups regarding serum osmolality may
partly explain the observed differences in fluid loads.
This emphasises the importance of also taking the total
osmotic pressure into consideration when choosing i.v.
fluid. Sodium concentration in the HH group differed sig-
nificantly from the controls after 24 hours and reflected
the content of sodium in the HH solution. This may influ-
Figure 2 Colloid osmotic pressure during cooling. Mixed effects model with mean and standard error. 
a) Colloid osmotic pressure in plasma. Mixed effects model with mean and standard error. Overall p < 0.001. Changes 24 vs. 0 hours. p < 0.001 (both 
groups). b) Colloid osmotic pressure in interstitial tissue. Mixed effects model with mean and standard error. Overall p < 0.001. Changes 24 vs. 0 hours. 
p = 0.001/p < 0.001 (HH/Control).
Figure 3 Systemic vascular resistance during cooling. Mixed ef-
fects model with mean and standard error. Overall p = 0.014. Changes 
24 vs. 0 hours. p = 0.008/p = 0.005 (HH/Control).
Figure 4 Cardiac index. Mixed effects model with mean and stan-
dard error. Overall p = 0.044. Changes 24 vs. 0 hours. p = 0.31/p = 0.019 
(HH/Control).
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shrinkage of cells and the prevention of endothelial
oedema [29].
Both groups demonstrated a comparable and signifi-
cant reduction in SVR, suggesting a similarity between
septic and post-cardiac arrest patients [30]. As hypov-
olemia leads to an increased SVR, our finding may reflect
a volume 'overload' [31]. Hypothermia and infusion of
vasopressors should induce vasoconstriction and centra-
lise circulation. However, intravenous fluid and inflam-
mation counteract vasoconstriction [32], and the overall
result was a significant decline in SVR in both the study
and the control group, also observed by Laurent et al. [1].
Small volume resuscitation with hypertonic saline dur-
ing CPR is described as feasible and safe [29], and, in a
study of critically ill ICU patients, HH was infused with-
out negative effects on renal function [33]. The VISEP
study [34] showed impaired renal function in sepsis
patients resuscitated with hydroxyethyl starch 200/0.5,
and there have been discussions concerning the safety of
these solutions in critically ill patients. Two of our
patients who received HH developed renal failure, one
due to arterial embolism, while the other developed fail-
ure weeks later. We consider the kidney failure in these
two patients to be unrelated to HH; its contribution can-
not be excluded, however.
Despite lower body temperature, CI was higher at 24
hours than on admission to the MICU. The increase was
significant in the control group. Laurent and collabora-
tors made the same observation when they monitored
more than 160 OHCA patients with pulmonary artery
catheter [1]. The improvement in CI in our study repre-
sents adequate fluid load and reduced stunning of the
heart. In a recent study, Jacobshagen et al. also demon-
Figure 5 Mean arterial pressure and central venous pressure (es-
timates and standard errors based on mixed effects models). Dif-
ference between slopes of curves at 0 hours, p = 0.20/0.12, and 
difference between curvatures p = 0.34/0.25 (MAP/CVP).
Table 5: Laboratory: Calculated mean using mixed effects model at 0, 8, 16 and 24 hours after admission to the MICU.
Time (hrs) 0a 8 16 24 p-valueb p-valuec Overall 
p-value
Na+ HH 139 148 153 151 <0.001 <0.001 <0.001
mmol/l Control 139 141 141 142 0.001
Cl- HH 100 116 125 121 <0.001 <0.001 <0.001
mmol/l Control 100 107 109 110 <0.001
K+ HH 4.1 3.8 3.9 3.9 0.542 0.798 0.869
mmol/l Control 4.1 4.2 4.0 3.8 0.343
Ca2+ HH 2.29 2.07 2.03 2.01 <0.001 0.689 <0.001
mmol/l Control 2.29 2.14 2.01 2.04 <0.001
Hb HH 15.1 13.8 13.0 12.1 <0.001 0.158 <0.001
g/dl Control 15.1 14.6 13.8 13.0 <0.001
Hematocrit HH 0.45 0.41 0.39 0.36 <0.001 0.183 <0.001
Control 0.45 0.44 0.40 0.39 <0.001
pH HH 7.28 7.29 7.31 7.33 0.098 0.253 0.043
Control 7.28 7.35 7.34 7.37 0.002
Osmolality HH 311 320 319 318 0.015 <0.001 <0.001
mosm/kg Control 311 302 299 299 <0.001
a Estimates based on mixed effects model, with no baseline differences assumed.
b Contrast from baseline at 24 hours
c Contrast between groups at 24 hours
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patients after cardiac arrest [35].
The clinical implication of the present study is that
post-cardiac arrest patients can be liberally infused with
crystalloids during the first 24 hours without cerebral
oedema resulting. They also have a high fluid require-
ment, which is partly because of increased extravasation,
measured by means of colloid osmotic pressures, sys-
temic vascular resistance and fluid calculations. Both
fluid regimens stabilise hemodynamics. The reduced
fluid load achieved by the application of HH should be
further investigated in cardiac arrest caused by asphyxia,
where a disrupted blood-brain barrier is more likely. The
lack of vasogenic brain oedema in these patients is
encouraging. This supports a liberal use of crystalloids,
especially due to an increased need for intravascular vol-
ume and the possible side effects of colloids. Further-
more, the impact on neurological outcome and survival
should be examined.
Conclusions
Post-cardiac arrest patients have high fluid requirements
during therapeutic hypothermia, probably due to
increased extravasation. The use of HH reduced the fluid
requirement significantly. However, the lack of brain
oedema in both groups suggests no superior fluid regi-
men. Cardiac index was significantly improved in the
group treated with crystalloids. Although we do not asso-
ciate HH with the renal failures that developed, caution
should be taken when using hypertonic starch solutions
in these patients.
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